FerruMax Pharmaceuticals, Inc. Report issue

For profit Phase 2
Founded: Boston MA United States (2008)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2013
NCT01873534
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

fmx-8 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 2)

Chronic Disease (Phase 2)

Kidney Diseases (Phase 1)

Renal Insufficiency, Chronic (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1